<!DOCTYPE html>
<html>
<head>
<title>Page Title</title>
    
    <link rel="shortcut icon" href="favicon.ico?v=1"/>
    <link rel="stylesheet" type="text/css" href="mywebsitedesign.css">
    <link rel="stylesheet" type="text/css" href="neondesign.css">
     <link rel="stylesheet" type="text/css" href="workspacedesign.css">
     
</head>
<body>
    <div id="base" class="base">
      <div id="matrix" class="matrix">
        <script src="workspacejs.js"></script>
      </div>
      <div id="demo"></div>
    </div>
    <div class="myinfo"></div>
    <div class="techbox"><h1>tech</h1></div>
    <div class="artbox"><h1>art</h1></div>
    <div class="lifebox"><h1>life</h1></div>
    <div class="logybox"><h1>logy</h1></div>
    <svg viewBox="0 0 100 100" width="500px">
  <path d="M25,2 L2,2 L2,25" fill="none" stroke="#6cf984" stroke-width="0.3" />
  <path d="M75,98 L98,98 L98,75" fill="none" stroke="#6cf984" stroke-width="0.3" />
    <h1 class="neofontsmart">
        <span1>s</span1>
        <span1>m</span1>
        <span1>a</span1>
        <span1>r</span1>
        <span1>t</span1>
        <span1>l</span1>
        <span1>i</span1>
        <span1>f</span1>
        <span1>e</span1>
    </h1>
</svg>
        <svg viewBox="0 0 100 100" width="500px" class="yellowtash">
  <path d="M25,2 L2,2 L2,25" fill="none" stroke="#6cf984" stroke-width="0.3" />
  <path d="M75,98 L98,98 L98,75" fill="none" stroke="#6cf984" stroke-width="0.3" />
    <h1 class="neofontyellowbox">
        <span1>y</span1>
        <span1>e</span1>
        <span1>l</span1>
        <span1>l</span1>
        <span1>o</span1>
        <span1>w</span1>
        <span1>b</span1>
        <span1>o</span1>
        <span1>x</span1>
    </h1>
</svg>
    <svg viewBox="0 0 100 100" width="250px" class="adbox1">
        
  <path d="M25,2 L2,2 L2,25" fill="none" stroke="#6cf984" stroke-width="0.3" />
  <path d="M75,98 L98,98 L98,75" fill="none" stroke="#6cf984" stroke-width="0.3" />
</svg>
    <svg viewBox="0 0 100 100" width="250px" class="adbox2">
  <path d="M25,2 L2,2 L2,25" fill="none" stroke="#6cf984" stroke-width="0.3" />
  <path d="M75,98 L98,98 L98,75" fill="none" stroke="#6cf984" stroke-width="0.3" />
</svg>
    <div class="menu"></div>
<a href="#" ><span></span>about me</a>
<a href="#" style="top: 35% ; left: 10%;" >my projects<span></span></a>
<a href="#" style="top: 40%; left: 10%" ><span></span>join me</a>
<a href="#" style="top: 45% ; left: 10%;" ><span></span>tutorial</a> 
<a href="#" style="top: 50% ; left: 10%;" ><span></span>essay</a>
<a href="#" style="top: 55% ; left: 10%;" >donate<span></span></a>
<a href="#" style="top: 60% ; left: 10%;" > contact me<span></span></a>
        <ul class="radr">
        <li></li>
        <li></li>
        <li></li>
        <li></li>
        <li></li>
        <li></li>
        <li></li>
        <li></li>
    </ul>
        <div class="yellowboxintro">
        Adoptive cell <br>therapy, including tumor infiltrating <br>lymphocytes and gene modified cells;
Cancer vaccine<br> development, including neoantigen vaccines;<br>
Intratumoral immunotherapy;
New macromo<br>lecules, such as bispecific or trispecific<br> antibodies, nanobodies, designed ankyrin repeat pro<br>teins and immunocytokines;
Biomarker <br>research aimed towards developing precision<br> immunotherapy, including <br>immuno-oncology <br>diagnostics both in peripheral blood <br>(ctDNA, chemokines profiles etc.)<br> and in the tumor, including tumor<br> mutational <br>burden, single cell analysis (genomics, transcriptomics<br>, proteomics), metabo<br>lomics, molecular imaging and microbiome;
First in human<br> trials, phase I and newly designed phase II trials.
    </div>
            <div class="yellowtashintro">
        Adoptive cell <br>therapy, including tumor infiltrating <br>lymphocytes and gene modified cells;
Cancer vaccine<br> development, including neoantigen vaccines;<br>
Intratumoral immunotherapy;
New macromo<br>lecules, such as bispecific or trispecific<br> antibodies, nanobodies, designed ankyrin repeat pro<br>teins and immunocytokines;
Biomarker <br>research aimed towards developing precision<br> immunotherapy, including <br>immuno-oncology <br>diagnostics both in peripheral blood <br>(ctDNA, chemokines profiles etc.)<br> and in the tumor, including tumor<br> mutational <br>burden, single cell analysis (genomics, transcriptomics<br>, proteomics), metabo<br>lomics, molecular imaging and microbiome;
First in human<br> trials, phase I and newly designed phase II trials.
    </div>
</body>
</html>
